View Older Stories View More Recent Stories

Aug 17, 2026 03:24PM EyePoint Inc. (EYPT) PT Lowered to $48 at Laidlaw
Aug 17, 2026 01:01PM Guggenheim Reiterates Buy Rating on EyePoint Inc. (EYPT)
Aug 17, 2026 12:51PM JPMorgan Downgrades EyePoint Inc. (EYPT) to Neutral
Aug 17, 2026 12:31PM EyePoint Inc. (EYPT) PT Lowered to $8 at Jefferies
Aug 17, 2026 12:07PM Stifel on EyePoint Inc. (EYPT): 'we think these data bode well for LUCIA (expected October) barring another unusual asymmetry'
Aug 17, 2026 09:30AM Cantor Fitzgerald Downgrades EyePoint Inc. (EYPT) to Neutral
Aug 17, 2026 08:41AM Citi cuts EyePoint price target to $17 from $35, keeps Buy, stock down 67%
Aug 5, 2026 07:05AM EyePoint Pharmaceuticals (EYPT) Misses Q2 EPS by 15c
Aug 5, 2026 06:31AM Citi opens 90-day upside catalyst call on EyePoint
Jul 29, 2026 06:53AM EyePoint Inc. (EYPT) PT Raised to $39 at Mizuho, 'Top Pick'
Jul 17, 2026 04:07PM EyePoint Pharmaceuticals settles False Claims Act case for $4.7M
Jul 15, 2026 04:07PM Stifel Starts EyePoint Inc. (EYPT) at Buy
Jul 8, 2026 06:14AM Cantor Fitzgerald Assumes EyePoint Inc. (EYPT) at Overweight
Jul 3, 2026 04:00PM These 5 stocks are added to The Mizuho Top Picks List for July
Jun 23, 2026 06:41AM Mizuho Reiterates Outperform Rating on EyePoint Inc. (EYPT)
May 7, 2026 03:18AM Guggenheim Reiterates Buy Rating on EyePoint Inc. (EYPT)
May 6, 2026 04:08PM Citi Opens 30-Day Upside Catalyst Watch on EyePoint Inc. (EYPT)
May 6, 2026 07:06AM EyePoint Pharmaceuticals (EYPT) Misses Q1 EPS by 17c
Mar 18, 2026 09:21AM RBC Capital on Biopharma: 'M&A Discussion, Whether Accurate Or Not, Can Drive Returns'
Mar 16, 2026 07:52AM Guggenheim Reiterates EyePoint (EYPT) at Buy, "EYPT remains one of our Top Picks"
Mar 9, 2026 08:19AM Mizuho Reiterates Outperform Rating on EyePoint Inc. (EYPT): "view recent weakness as a buying opportunity"
Mar 6, 2026 02:19PM EyePoint Inc. (EYPT) PT Raised to $35 at Citi
Mar 5, 2026 06:52AM EyePoint Inc. (EYPT) PT Raised to $30 at H.C. Wainwright
Mar 4, 2026 02:56PM EyePoint Inc. (EYPT) PT Raised to $29 at Chardan
Mar 4, 2026 07:03AM EyePoint Pharmaceuticals (EYPT) Misses Q4 EPS by 6c
Feb 17, 2026 12:57PM Guggenheim Reiterates EyePoint at (EYPT) at Buy, 'remains one of our Top Picks'
Feb 5, 2026 08:54AM RBC Capital on EyePoint Inc. (EYPT): 'We See Recent Weakness as Buying Opportunity'
Feb 2, 2026 08:39AM Mizuho on EyePoint Inc. (EYPT): 'Competitor P3 Data Coming, So Expect Volatility; Recent Weakness Provides an Opportunity'
Jan 7, 2026 09:55AM Mizuho: 'we again highlight EYPT as a top pick for 2026'
Jan 7, 2026 09:02AM RBC Capital on EyePoint Inc. (EYPT): 'we see weighted avg. upside of ~60% into EYPT's wAMD Phase III readout'
Jan 7, 2026 07:03AM EyePoint advances retinal drug trials with 2026 data readouts expected
Jan 2, 2026 10:00PM Here are Mizuho's top Biotech pick for 2026
Dec 21, 2025 08:00PM Here's the list of top biotech stocks to own for 2026
Dec 9, 2025 10:49AM Mizuho on EyePoint Inc. (EYPT): 'Competitor Makes a Move for the Pole Position; Reiterate OP, as We're Not Concerned'
Dec 8, 2025 09:55AM EyePoint Pharmaceuticals (EYPT) Changes Names to Eyepoint Inc - SEC
Nov 20, 2025 06:41AM H.C. Wainwright Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Nov 5, 2025 07:05AM EyePoint Pharmaceuticals (EYPT) Misses Q3 EPS by 8c
Oct 20, 2025 06:55AM Mizuho Reiterates Outperform Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Oct 14, 2025 04:24PM EyePoint Pharmaceuticals (EYPT) files mixed shelf
Oct 2, 2025 06:38AM Mizuho Reiterates Outperform Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Aug 14, 2025 01:52PM EyePoint Pharmaceuticals, Inc. (EYPT) PT Raised to $28 at Mizuho
Aug 6, 2025 07:03AM EyePoint Pharmaceuticals (EYPT) Misses Q2 EPS by 4c
May 30, 2025 06:44AM H.C. Wainwright Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
May 27, 2025 12:20PM JPMorgan on EyePoint Pharmaceuticals, Inc. (EYPT): 'We are pleased to see EyePoint’s continued execution'
May 16, 2025 05:35AM EyePoint Pharmaceuticals, Inc. (EYPT) PT Lowered to $26 at Mizuho
May 7, 2025 07:06AM EyePoint Pharmaceuticals (EYPT) Tops Q1 EPS by 2c
Mar 17, 2025 10:33AM Mizuho Reiterates Outperform Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Mar 17, 2025 10:00AM These 11 stocks are Mizuho's Aging Intelligence (AI) top picks
Mar 6, 2025 07:24AM H.C. Wainwright Reiterates Buy Rating on EyePoint Pharmaceuticals, Inc. (EYPT)
Mar 5, 2025 07:04AM EyePoint Pharmaceuticals (EYPT) Misses Q4 EPS by 14c
View More Recent Stories View Older Stories